Hessam Kakavand: Rethinking Thrombotic Risk in Modern Cancer Therapy
Hessam Kakavand, Clinical Pharmacist at Rasool Akram Hospital, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Circulation, adding:
“Honored to share that our comprehensive review, ‘Anticancer Drugs and Cancer-Associated Thrombosis,’ has been published in Circulation!
As cancer therapies continue to transform patient outcomes, they also bring new cardiovascular and vascular challenges.
Cancer-associated thrombosis remains a major cause of morbidity and mortality, yet the thrombotic risks associated with many contemporary anticancer therapies are often underrecognized.
In this review, we examine the evidence linking anticancer therapies to venous and arterial thrombotic events, explore the underlying pathobiological mechanisms, summarize current guideline recommendations, and discuss emerging cardio-oncology perspectives on risk assessment and management.
This work is also a reminder that advancing patient care is never the result of a single discipline. It is made possible through the collective expertise of cardiologists, hematologists, oncologists, and of course clinical pharmacists, working together to address increasingly complex clinical challenges.
I truly believe that multidisciplinary collaboration is the foundation of the future of cardio-oncology.
I am deeply grateful to my outstanding co-authors and colleagues, Maryam Kouchakzadeh, Parham Sadeghipour, Armin Pasukanovic, Jean Connors, Adam Cuker, Craig Beavers, Benjamin Van Tassell, Antonio Abbate, Nicola Potere, Behnood Bikdeli, and Jayant Raikhelkar whose expertise, thoughtful discussions, and collaborative spirit made this work possible.
A very special thanks to my mentor Azita H. Talasaz for her exceptional leadership and vision throughout this project. Your guidance has been invaluable, and I am sincerely grateful for the opportunity to learn from and work alongside you.”
Title: Anticancer Drugs and Cancer-Associated Thrombosis
Authors: Hessam Kakavand, Maryam Aghakouchakzadeh, Parham Sadeghipour, Armin Pasukanovic, Jean M. Connors, Adam Cuker, Craig Beavers, Benjamin Van Tassell, Michelle Weisfelner Bloom, Behnood Bikdeli, Antonio Abbate, Nicola Potere, Jayant K. Raikhelkar, Azita H. Talasaz
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 6, 2026, 04:07Moussa Zein Aldine: Acute Coronary Syndrome Every Minute Matters
-
Oct 6, 2026, 03:13Patrick Taylor: Glow Stack Trend What the Evidence Really Shows
-
Oct 6, 2026, 02:59Preventing Hospital Associated Venous Thromboembolism – Thrombosis Canada
-
Oct 6, 2026, 02:42Treatment of Iron Deficiency With and Without Anemia – American Society of Hematology
-
Oct 6, 2026, 02:36Mouna Sassi: When Clinical and Laboratory Perspectives Meet in Thrombosis Care
-
Oct 6, 2026, 02:35Lucia Stefanini: Platelet Dysfunction and Oxidized Phospholipids in MASLD
-
Oct 6, 2026, 02:18Pablo Corral: Association of Lp(a) With Coronary Atherosclerosis and CV Events
-
Oct 5, 2026, 22:55Steve Humphreys: A Big Thank You to BSHT for Providing Me With a Recent Skills Exchange Award
-
Oct 5, 2026, 22:52William McKeown: Great to Be in Istanbul for the Opening of the EHC 2026